Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Lyfegen and Switzerland's EGK Insurance Partner to Reduce Prices for High-cost Drugs
Lyfegen, a global healthtech SaaS company driving the world’s transition from volume to value-based healthcare […]
Hansa Biopharma Announces Positive Topline Data from a Study in Antibody Mediated Rejection (AMR) Post Kidney Transplantation
Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, today announces positive […]
Medcase & NTT DATA Sign a Definitive Agreement to Enable Healthcare AI Developers a Holistic Solution
Medcase, a leading solution provider for healthcare AI, and NTT DATA, a digital business and IT […]
Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Exscientia has announced clinical trial application (CTA) approval of IGNITE-AI, enabling site activation in its […]
IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer
IDEAYA Biosciences, a synthetic lethality-focused precision medicine oncology company committed to the discovery and development […]
Envirotainer Significantly Expands Global CryoSure® Network with New Singapore Station
Envirotainer, the global market leader in secure cold chain solutions for shipment of pharmaceuticals, has […]
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Biocytogen Pharmaceuticals has announced that it has entered into an evaluation and option agreement with […]
Escient Pharmaceuticals Announces $120 Million Series C Financing
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of […]
Vial Announces the Addition of Dr. Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board
Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Marc Hoffmann, […]
Almirall Joins FACILITATE, a Patient-driven Innovative Medicines Initiative (IMI) Project
Almirall (ALM), a global biopharmaceutical company focused on skin health, has today announced that it […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more